A groundbreaking new blood test that can detect more than 50 forms of cancer will be tested in 2021.
The cancer screening kit, based on the ability of a nematode to smell cancer cells in urine, costs $ 90.
The researchers distinguish the different characteristics of non-coding RNA molecules in benign and malignant thyroid cells, thereby distinguishing benign and malignant tumors.
Israel's Medial company offers less invasive solutions, based on more data for drug-resistant patients.
Until now, the only method to test cancer was a biopsy. But now, just testing blood can do.